SILVER SPRING, Md.—Kilitch Healthcare India Limited, the manufacturer of more than two dozen eye drops subject to a recent U.S. safety warning, has recalled the products, which were sold by CVS Health, Target, Rite Aid and other national retailers. The India-based manufacturer issued the recall earlier this week and the Food and Drug Administration (FDA) published the notice on Wednesday. These products are being recalled due to potential safety concerns after FDA investigators found insanitary conditions.

The products were distributed nationwide to wholesalers, retailers and via the product distributor, Velocity Pharma LLC. According to the FDA notice, Kilitch Healthcare India Limited is notifying its distributor Velocity Pharma LLC and its distributor Velocity Pharma LLC shall further be notifying the wholesalers and retailers via mail of this voluntary recall and is arranging for return of all impacted products listed above. Consumers, distributors and retailers that have any product which is being recalled should cease distribution of the product. Consumers should stop using the recalled eye drops and may return any of the above listed products to the place of purchase, according to the FDA.

Kilitch Healthcare India said it has not received any reports of adverse events related to its products. The eye drops carry expiration dates between November 2023 and September 2025.

As reported in VMAIL, the FDA last month warned consumers not to purchase certain types of eye drops from CVS, Rite Aid and Target store brands because they could cause eye infections leading to partial vision loss or blindness. Eye drops from Walmart (Equate brand), Cardinal Health's Leader and Rugby brands, and Velocity Pharma were also included in the warning. The FDA said in its initial warning that agency inspectors found unsanitary conditions and bacterial contamination at the factory where the drops were manufactured.